The role of immunohistochemistry in the evaluation of gynecologic pathology part 2: A comparative study between two academic institutes

Annals of Diagnostic Pathology

Volumn 19, Issue 5, 2015, Pages 296-300

  Desouki, Mohamed Mokhtar ^a   Chamberlain, Benjamin K ^a   Li, Zaibo ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Gynecologic pathology; Immunohistochemistry; ki 67; p16; p53

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 7; ESTROGEN RECEPTOR; HEPATOCYTE NUCLEAR FACTOR 1BETA; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; PROTEIN P16; PROTEIN P53; TRANSCRIPTION FACTOR GATA 3; VIMENTIN; WT1 PROTEIN; BIOLOGICAL MARKER; TUMOR MARKER;

ADENOCARCINOMA; ARTICLE; BASEMENT MEMBRANE; CARCINOSARCOMA; CERVICAL CARCINOSARCOMA; CERVICAL SQUAMOUS CELL CARCINOMA; CLINICAL EVALUATION; COMPARATIVE STUDY; ENDOCERVICAL ADENOCARCINOMA; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; FEMALE; GYNECOLOGIC DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SQUAMOUS INTRAEPITHELIAL GYNECOLOGIC LESION; UROGENITAL TRACT TUMOR; UTERINE CERVIX CARCINOMA; VULVA TUMOR; VULVAR INTRAEPITHELIAL NEOPLASIA; CLINICAL TRIAL; FEMALE GENITAL TRACT TUMOR; METABOLISM; MULTICENTER STUDY; PATHOLOGY; PROCEDURES; TERTIARY CARE CENTER; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; BIOMARKERS; BIOMARKERS, TUMOR; FEMALE; GENITAL DISEASES, FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; RETROSPECTIVE STUDIES; TERTIARY CARE CENTERS;

EID: 84941598842     PISSN: 10929134     EISSN: 15328198     Source Type: Journal    
DOI: 10.1016/j.anndiagpath.2015.06.005     Document Type: Article

References (28)

1. L.L. Matos, D.C. Trufelli, M.G. de Matos, and M.A. da Silva Pinhal Immunohistochemistry as an important tool in biomarkers detection and clinical practice Biomark Insights 5 2010 9 20
2. V.M. Marjoniemi Immunohistochemistry in gynaecological pathology: a review Pathology 36 2004 109 119
3. W.G. McCluggage Immunohistochemical and functional biomarkers of value in female genital tract lesions Int J Gynecol Pathol 25 2006 101 120
4. W.G. McCluggage Recent advances in immunohistochemistry in the diagnosis of ovarian neoplasms J Clin Pathol 53 2000 327 334
5. W.G. McCluggage Recent advances in immunohistochemistry in gynaecological pathology Histopathology 40 2002 309 326
6. M.R. Nucci, D.H. Castrillon, H. Bai, B.J. Quade, T.A. Ince, D.R. Genest, and et al. Biomarkers in diagnostic obstetric and gynecologic pathology: a review Adv Anat Pathol 10 2003 55 68
7. H. Yaziji, and A.M. Gown Immunohistochemical analysis of gynecologic tumors Int J Gynecol Pathol 20 2001 64 78
8. K. Mittal, R. Soslow, and W.G. McCluggage Application of immunohistochemistry to gynecologic pathology Arch Pathol Lab Med 132 2008 402 423
9. College of American Pathologists IHC Billing Education vol. 2014 2014
10. B.K. Chamberlain, O. Fadare, and M.M. Desouki The role of immunohistochemistry in the evaluation of gynecologic pathology: a single institutional experience Ann Diagn Pathol 19 2015 88 90
11. T. Sano, T. Oyama, K. Kashiwabara, T. Fukuda, and T. Nakajima Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions Am J Pathol 153 1998 1741 1748
12. A.S. Leong Quantitation in immunohistology: fact or fiction? A discussion of variables that influence results Appl Immunohistochem Mol Morphol 12 2004 1 7
13. I. Lesnikova, M. Lidang, S. Hamilton-Dutoit, and J. Koch p16 as a diagnostic marker of cervical neoplasia: a tissue microarray study of 796 archival specimens Diagn Pathol 4 2009 22 [1-7]
14. Y. Yin, C.W. Stephen, M.G. Luciani, and R. Fahraeus p53 Stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products Nat Cell Biol 4 2002 462 467
15. V. Marcel, S. Perrier, M. Aoubala, S. Ageorges, M.J. Groves, A. Diot, and et al. Delta160p53 is a novel N-terminal p53 isoform encoded by Delta133p53 transcript FEBS Lett 584 2010 4463 4468
16. H. Lassus, A. Leminen, J. Lundin, P. Lehtovirta, and R. Butzow Distinct subtypes of serous ovarian carcinoma identified by p53 determination Gynecol Oncol 91 2003 504 512
17. M. Kobel, S.E. Kalloger, J. Carrick, D. Huntsman, H. Asad, E. Oliva, and et al. A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary Am J Surg Pathol 33 2009 14 21
18. N. Niikura, S. Masuda, N. Kumaki, T. Xiaoyan, M. Terada, M. Terao, and et al. Prognostic significance of the Ki67 scoring categories in breast cancer subgroups Clin Breast Cancer 14 2014 323 329.e3
19. R. Koivisto-Korander, R. Butzow, A.M. Koivisto, and A. Leminen Immunohistochemical studies on uterine carcinosarcoma, leiomyosarcoma, and endometrial stromal sarcoma: expression and prognostic importance of ten different markers Tumour Biol 32 2011 451 459
20. S. Yamamoto, H. Tsuda, S. Aida, H. Shimazaki, S. Tamai, and O. Matsubara Immunohistochemical detection of hepatocyte nuclear factor 1beta in ovarian and endometrial clear-cell adenocarcinomas and nonneoplastic endometrium Hum Pathol 38 2007 1074 1080
21. O. Fadare, and S.X. Liang Diagnostic utility of hepatocyte nuclear factor 1-beta immunoreactivity in endometrial carcinomas: lack of specificity for endometrial clear cell carcinoma Appl Immunohistochem Mol Morphol 20 2012 580 587
22. O. Fadare, C. Zhao, D. Khabele, V. Parkash, C.M. Quick, K. Gwin, and et al. Comparative analysis of Napsin A, alpha-methylacyl-coenzyme A racemase (AMACR, P504S), and hepatocyte nuclear factor 1 beta as diagnostic markers of ovarian clear cell carcinoma: an immunohistochemical study of 279 ovarian tumours Pathology 47 2015 105 111
23. S.L. Kenny, H.A. McBride, J. Jamison, and W.G. McCluggage Mesonephric adenocarcinomas of the uterine cervix and corpus: HPV-negative neoplasms that are commonly PAX8, CA125, and HMGA2 positive and that may be immunoreactive with TTF1 and hepatocyte nuclear factor 1-beta Am J Surg Pathol 36 2012 799 807
24. A.A. Shah, H.F. Frierson Jr., and H.P. Cathro Analysis of immunohistochemical stain usage in different pathology practice settings Am J Clin Pathol 138 2012 831 836
25. R.W. Wetherington, H.S. Cooper, T. Al-Saleem, D.S. Ackerman, R. Adams-McDonnell, W. Davis, and et al. Clinical significance of performing immunohistochemistry on cases with a previous diagnosis of cancer coming to a national comprehensive cancer center for treatment or second opinion Am J Surg Pathol 26 2002 1222 1230
26. S.S. Raab The cost-effectiveness of immunohistochemistry Arch Pathol Lab Med 124 2000 1185 1191
27. A.D. Tabrizi, S.E. Kalloger, M. Kobel, J. Cipollone, C.D. Roskelley, E. Mehl, and et al. Primary ovarian mucinous carcinoma of intestinal type: significance of pattern of invasion and immunohistochemical expression profile in a series of 31 cases Int J Gynecol Pathol 29 2010 99 107
28. P.G. Chu, L. Chung, L.M. Weiss, and S.K. Lau Determining the site of origin of mucinous adenocarcinoma: an immunohistochemical study of 175 cases Am J Surg Pathol 35 2011 1830 1836